Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Uther.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 17 | 99.81% | Jun 8, 2026 |
| Tirzepatide | 16 | 99.78% | Jul 20, 2026 |
| BPC-157 | 11 | 99.8% | Mar 6, 2026 |
| Tesamorelin | 10 | 99.69% | Jul 1, 2026 |
| Ipamorelin | 9 | 99.42% | Jun 8, 2026 |
| GHK-Cu | 8 | 99.9% | Jul 20, 2026 |
| CJC-1295 No DAC | 5 | 99.84% | Mar 7, 2026 |
| Survodutide | 4 | 99.19% | Apr 23, 2026 |
| PT-141 | 4 | 99.91% | Apr 28, 2026 |
| Cagrilintide | 4 | 99.51% | Jun 1, 2026 |
| Semaglutide | 3 | 99.83% | Dec 29, 2025 |
| Mazdutide | 2 | 99.78% | Oct 9, 2025 |
| Melanotan II | 2 | 99.56% | Oct 9, 2025 |
| TB-500 | 2 | 99.45% | Mar 2, 2026 |
| CJC-1295 DAC | 1 | n/a | Nov 25, 2025 |
| TB-500 Thymosin Beta-4 | 1 | 99.8% | Feb 10, 2026 |
| TB-500 Fragment 17-23 | 1 | 99.8% | Mar 7, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| GHK-Cu | HK50-0522 | 99.9% | Lab E | Jul 20, 2026 | verify |
| Tirzepatide | ZE300517 | 99.9% | Lab E | Jul 20, 2026 | verify |
| Tesamorelin | TE10-0515 | 99.9% | Lab E | Jul 1, 2026 | verify |
| Ipamorelin | IP10-0428 | 99.9% | Lab G | Jun 8, 2026 | verify |
| Retatrutide | RE30-0509 | 99.8% | Lab G | Jun 8, 2026 | verify |
| Tesamorelin | TE20-0429 | 99.8% | Lab G | Jun 8, 2026 | verify |
| Ipamorelin | IP10-0428 | n/a | Lab G | Jun 6, 2026 | verify |
| Retatrutide | RE30-0509 | n/a | Lab G | Jun 6, 2026 | verify |
| Tesamorelin | TE20-0429 | n/a | Lab G | Jun 6, 2026 | verify |
| Cagrilintide | CAG5-0328 | 99.8% | Lab E | Jun 1, 2026 | verify |
| Ipamorelin | IP10-0325 | 97.7% | Lab E | May 8, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | Apr 28, 2026 | verify |
| PT-141 | n/a | 99.9% | Lab E | Apr 28, 2026 | verify |
| Retatrutide | RE20-0115 | 99.8% | Lab E | Apr 28, 2026 | verify |
| Tirzepatide | ZE60-0118 | n/a | Lab E | Apr 28, 2026 | verify |
| Retatrutide | RT30-1128 | 99.9% | Lab E | Apr 28, 2026 | verify |
| Survodutide | SUR100929 | 99.9% | Lab E | Apr 23, 2026 | verify |
| Tesamorelin | TE20-0303 | 99.7% | Lab G | Mar 25, 2026 | verify |
| Tesamorelin | TE20-0303 | 99.8% | Lab G | Mar 20, 2026 | verify |
| Cagrilintide | n/a | 99.2% | Lab G | Mar 13, 2026 | verify |
| CJC-1295 No DAC | CJND10-0113 | 99.9% | Lab G | Mar 7, 2026 | verify |
| TB-500 Fragment 17-23 | TBF10-0104 | 99.8% | Lab G | Mar 7, 2026 | verify |
| BPC-157 | bp10-0114 | 99.9% | Lab E | Mar 6, 2026 | verify |
| PT-141 | n/a | 99.9% | Lab E | Mar 6, 2026 | verify |
| Ipamorelin | ip10-0106 | 99.9% | Lab E | Mar 6, 2026 | verify |
Showing 25 most recent of 100. Search the full database on the CoA page.
Sell or represent Uther? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/uther/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/uther.svg" alt="Uther: lab tested, 100 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.